Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis.
about
Current evidence and applications of photodynamic therapy in dermatologyComparative Study of Photodynamic Therapy with Topical Methyl Aminolevulinate versus 5-Aminolevulinic Acid for Facial Actinic Keratosis with Long-Term Follow-Up.Actinic keratosis: update on field therapy.A network meta-analysis of the relative efficacy of treatments for actinic keratosis of the face or scalp in EuropePhotodynamic therapy downregulates the function of regulatory T cells in patients with esophageal squamous cell carcinoma.Light-emitting diodes in photodynamic therapy in non-melanoma skin cancers--own observations and literature review.Light Fractionation Significantly Increases the Efficacy of Photodynamic Therapy Using BF-200 ALA in Normal Mouse Skin.Cyclooxygenase in Cancer Prevention and Treatments for Actinic KeratosisOncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions.A review of BF-200 ALA for the photodynamic treatment of mild-to-moderate actinic keratosis.Photodynamic therapy in dermatology beyond non-melanoma cancer: an update.Follow-up analysis of the efficacy of photodynamic therapy in actinic keratosis: reply from the authors.Long-term follow-up of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis.Photodynamic therapy using intense pulsed light for treating actinic keratoses and photoaged skin of the dorsal hands: a randomized placebo-controlled study.Real-world approach to actinic keratosis management: practical treatment algorithm for office-based dermatology.Follow-up analysis of the efficacy of photodynamic therapy in actinic keratosis.Overview on Topical 5-ALA Photodynamic Therapy Use for Non Melanoma Skin Cancers
P2860
Q26822964-4B363CC6-D6BB-493D-9286-60495212ACEDQ33801978-90D236E9-6C45-4A66-BE72-D7642266076BQ34441431-C2A976E3-8543-47E3-B9C2-690647205864Q35180653-9B8AB387-CC58-4848-B09E-3A977E8DA3A1Q35203371-96F7DAB4-37CB-47BB-98B4-21FF76CAEA05Q35886599-0A2A3274-9A04-4CF0-AB63-4504F6143B9BQ35922404-85104A4E-6D54-490A-90DF-2B9211509856Q37621197-F103B014-6C1F-42E8-9827-516868074645Q37676077-CDB85CAE-EE5F-4EEE-BB65-E8414BADA21BQ38626385-79A90529-B579-497C-800B-E4606D0211AEQ39396536-C835295C-088F-4046-8767-89A7F59BDD32Q44321021-E33FCFCD-3A63-4B5F-82D7-23A373B94812Q44742949-3AB445BB-B75B-42D2-A19E-F5131D47BAF4Q47677093-6E7E2DA0-12E2-4B91-AD87-C217D07DC7FEQ50225349-0413DC4D-A86D-45C8-840A-BCDCF706D406Q52882944-C362953C-0FF3-4FFE-86F0-65CA21EA104DQ59044946-B4B6CF68-06B9-4C80-B656-23EC33E8F0A3
P2860
Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Long-term (6 and 12 months) fo ...... reatment of actinic keratosis.
@en
type
label
Long-term (6 and 12 months) fo ...... reatment of actinic keratosis.
@en
prefLabel
Long-term (6 and 12 months) fo ...... reatment of actinic keratosis.
@en
P2093
P2860
P356
P1476
Long-term (6 and 12 months) fo ...... treatment of actinic keratosis
@en
P2093
AK-CT002 Study Group
AK-CT003 Study Group
C Oster-Schmidt
F Borrosch
F Hübinger
G Krähn-Senftleben
P2860
P304
P356
10.1111/BJD.12158
P407
P577
2013-04-01T00:00:00Z